Results 51 to 60 of about 1,828,178 (224)

Hedinger Syndrome—Lessons Learnt: A Single-Center Experience

open access: yesJournal of Cardiovascular Development and Disease, 2023
Background: Hedinger syndrome (HS) or carcinoid heart disease (CD) is a rare and challenging manifestation of malignant neuroendocrine tumours (NETs) involving the heart.
Mohamed El Gabry   +6 more
doaj   +1 more source

The Heart Team during the Pandemic: A Case Report of Bio-Prosthesis Degeneration Treated with Valve in Valve Implantation

open access: yesJournal of Cardiovascular Echography
The pandemic changed the type of patients. The concept of “patient at the center” became concrete. The execution of simple consultancy was overcome to create effective collaboration and fruitful exchanges between specialists. The “Heart Team” model is on increasing affirmation.
Manes, Maria Teresa   +6 more
openaire   +2 more sources

Transcatheter Tricuspid Valve Replacement for Residual Tricuspid Regurgitation After TEER

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Residual or recurrent tricuspid regurgitation (TR) after prior transcatheter tricuspid edge‐to‐edge (T‐TEER) repair occurs in about 12% of patients within 1 year. Since surgical tricuspid valve repair or replacement is of high risk, treatment options remain scarce.
Fabian Voß   +14 more
wiley   +1 more source

Various clinical factors’ influence on long-term results of valve prosthetic surgery in heart valve disease

open access: yesКардиоваскулярная терапия и профилактика, 2005
Aim. To assess factors influencing the long-term results of valve prosthetic surgery in heart valve disease. Material and methods. In total, 310 patients with heart valve surgery in anamnesis were examined: 168 females (54%), 142 males (46%); mean age 54.
L. I. Murzabekova, V. A. Orlov
doaj  

Emergently Alteration of Procedural Strategy During Transcatheter Aortic Valve Replacement to Prevent Coronary Occlusion: A Case Report

open access: yesFrontiers in Cardiovascular Medicine, 2022
BackgroundCoronary occlusion is an uncommon but fatal complication of transcatheter aortic valve replacement (TAVR) with a poor prognosis.Case PresentationA patient with symptomatic severe bicuspid aortic valve stenosis was admitted to a high-volume ...
Hanyi Dai   +15 more
doaj   +1 more source

Percutaneous pulmonary valve implantation in humans - Results in 59 consecutive patients [PDF]

open access: yes, 2005
Background - Right ventricular outflow tract (RVOT) reconstruction with valved conduits in infancy and childhood leads to reintervention for pulmonary regurgitation and stenosis in later life.Methods and Results - Patients with pulmonary regurgitation ...
Coats, L   +12 more
core  

Clinical Outcomes of the Allegra Transcatheter System in Bioprosthetic Aortic Valve Failure: A Multicentre Valve‐in‐Valve Registry

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Introduction The prevalence of bioprosthetic aortic valve failure is increasing due to the broader use of bioprosthetic valves, both surgical and transcatheter, and an ageing population. Registry data indicate a higher risk of coronary obstruction and elevated gradients following valve‐in‐valve transcatheter aortic valve implantation (TAVI ...
Hilal Khan   +14 more
wiley   +1 more source

Late migration of transcatheter aortic valve replacement prosthesis [PDF]

open access: yesБългарска кардиология
Transcatheter aortic valve replacement (TAVR) is an established therapy for severe aortic stenosis, particularly in high-risk surgical candidates.
G. Goranov, E. Georgieva
doaj   +3 more sources

Cinefluoroscopy for assessment of mechanical heart valves with suspected dysfunction

open access: yesFrontiers in Cardiovascular Medicine, 2022
BackgroundMechanical heart valves (MHVs) are preferred prosthesis types in many, especially younger patients who need surgical valve replacement.
Anselm A. Derda   +8 more
doaj   +1 more source

Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis

open access: yesJournal of the American College of Cardiology, 2004
This study was done to assess the results of percutaneous heart valve (PHV) implantation in non-surgical patients with end-stage calcific aortic stenosis.Replacement of PHV has been shown to be feasible in animals and humans. We developed a PHV composed of three pericardial leaflets inserted within a balloon-expandable stainless steel stent.
Cribier, Alain   +10 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy